Symbol="ADMP"
AssetType="Common Stock"
Name="Adamis Pharma"
Description="Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and markets products in the therapeutic areas of allergies and respiratory diseases in the United States. The company is headquartered in San Diego, California."
CIK="887247"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="11682 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="11133700"
EBITDA="-22324544"
PERatio="None"
PEGRatio="0"
BookValue="-4.071"
DividendPerShare="0"
DividendYield="0"
EPS="-11.33"
RevenuePerShareTTM="2.348"
ProfitMargin="0"
OperatingMarginTTM="-4.664"
ReturnOnAssetsTTM="-0.744"
ReturnOnEquityTTM="-7.85"
RevenueTTM="5054600"
GrossProfitTTM="-1431408"
DilutedEPSTTM="-11.33"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.259"
AnalystTargetPrice="0.42"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="17.64"
PriceToBookRatio="8.62"
EVToRevenue="15.59"
EVToEBITDA="-0.784"
Beta="1.259"
num_52WeekHigh="27.8"
num_52WeekLow="1.28"
num_50DayMovingAverage="2.191"
num_200DayMovingAverage="8.86"
SharesOutstanding="2790400"
DividendDate="None"
ExDividendDate="None"
symbol="ADMP"
open="1.28"
high="2.09"
low="1.28"
price="1.33"
volume="23768341.00"
latest_trading_day="2023-08-02"
previous_close="3.99"
change="-2.66"
change_percent="-66.6667%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="99"
trend_strength="Absent or Weak Trend"
buying_signal="High Volatility / Hold Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="TRUE"
Aroon_momentum="1"
Volume_recent_avg="1335878"
Change_recent_avg="0.01"
Delta_recent_avg="0.2"
Variance_recent_avg="0.1"
Change_ratio_recent_avg="-1.88"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="TRUE"
Aroon_momentum_positive="1"
Aroon_momentum_negative="99"
image_negative_thumbnail_id_1="512"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0093.jpeg"
image_negative_thumbnail_id_2="136"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0040.jpeg"
image_neutral_thumbnail_id_1="582"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0017.jpeg"
image_neutral_thumbnail_id_2="555"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0044.jpeg"
image_positive_thumbnail_id_1="625"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0083.jpeg"
image_positive_thumbnail_id_2="701"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0007.jpeg"
image_professor_thumbnail_id_1="1168"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
image_professor_thumbnail_id_2="1200"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0034.jpeg"
